Ardsley Advisory Partners’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-12,500
| Closed | -$25K | – | 186 |
|
|
2019
Q3 | $25K | Hold |
12,500
| – | – | 0.01% | 108 |
|
|
2019
Q2 | $27K | Buy |
12,500
+2,134
| +21% | +$4.61K | ﹤0.01% | 129 |
|
|
2019
Q1 | $33K | Buy |
+10,366
| New | +$33K | 0.01% | 115 |
|
|
2017
Q4 | – | Sell |
-36,200
| Closed | -$77K | – | 171 |
|
|
2017
Q3 | $77K | Sell |
36,200
-3,800
| -10% | -$8.08K | 0.01% | 116 |
|
|
2017
Q2 | $180K | Hold |
40,000
| – | – | 0.03% | 111 |
|
|
2017
Q1 | $120K | Buy |
40,000
+11,100
| +38% | +$33.3K | 0.02% | 122 |
|
|
2016
Q4 | $80K | Hold |
28,900
| – | – | 0.01% | 110 |
|
|
2016
Q3 | $90K | Hold |
28,900
| – | – | 0.01% | 134 |
|
|
2016
Q2 | $148K | Buy |
28,900
+5,000
| +21% | +$25.6K | 0.03% | 126 |
|
|
2016
Q1 | $98K | Buy |
23,900
+500
| +2% | +$2.05K | 0.02% | 123 |
|
|
2015
Q4 | $190K | Hold |
23,400
| – | – | 0.02% | 117 |
|
|
2015
Q3 | $197K | Hold |
23,400
| – | – | 0.05% | 111 |
|
|
2015
Q2 | $220K | Buy |
23,400
+8,400
| +56% | +$79K | 0.03% | 142 |
|
|
2015
Q1 | $139K | Buy |
+15,000
| New | +$139K | 0.02% | 146 |
|